Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports safety, tolerability, and immunogenicity data for a booster dose of the live varicella-zoster vaccine (Zoster Vaccine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Zoster Vaccine, Live (varicella-zoster vaccine live)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster, Varicella-zoster Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2013-05-29